Literature DB >> 21233148

Do subjective cognitive complaints correlate with cognitive impairment in systemic lupus erythematosus? A Danish outpatient study.

A Vogel1, S Bhattacharya, J L Larsen, S Jacobsen.   

Abstract

This study examined the prevalence of cognitive impairment and its association with depressive symptoms and self-reported cognitive complaints in Danish outpatients with systemic lupus erythematosus (SLE). Fifty-seven consecutive female SLE-outpatients were examined with a comprehensive neuropsychological test-battery, a 20-item self-administered Perceived Deficits Questionnaire (PDQ) and a self-rated depression scale (Major Depression Inventory). Twenty-two patients (38.5%) were classified as cognitively impaired, mostly with deficits in executive functions and attention. Among cognitively impaired patients only 18.2% had significantly higher PDQ scores than the normal range. PDQ scores were highly correlated to depressive symptoms (r = 0.67, p < 0.001). Only two neuropsychological tests were significantly correlated with subjective cognitive complaints. When these variables and self-rated depression score were entered into a regression model both depression score and Symbol Digit Modalities Test performances were significantly associated with the PDQ score. In conclusion, cognitive impairments were common in this group of (mild) SLE outpatients, but the level of significant subjective cognitive complaints was low even among patients with cognitive impairment. Affective status may influence subjective experience of cognitive functions even more than cognitive functioning itself, and absence of subjective cognitive complaints did not exclude the presence of cognitive impairments.

Entities:  

Mesh:

Year:  2011        PMID: 21233148     DOI: 10.1177/0961203310382430

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  13 in total

1.  Validity of brief screening tools for cognitive impairment in rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Laura J Julian; Jinoos Yazdany; Laura Trupin; Lindsey A Criswell; Edward Yelin; Patricia P Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-03       Impact factor: 4.794

2.  Geriatric Assessment of Physical and Cognitive Functioning in a Diverse Cohort of Systemic Lupus Erythematosus Patients: A Pilot Study.

Authors:  Laura Plantinga; Benjamin D Tift; Charmayne Dunlop-Thomas; S Sam Lim; C Barrett Bowling; Cristina Drenkard
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-08-27       Impact factor: 4.794

3.  Cognitive Impairments and Subjective Cognitive Complaints in Fabry Disease: A Nationwide Study and Review of the Literature.

Authors:  Josefine Loeb; Ulla Feldt-Rasmussen; Christoffer Valdorff Madsen; Asmus Vogel
Journal:  JIMD Rep       Date:  2018-04-14

4.  Global Cognitive Impairment in Systemic Lupus Erythematosus Patients: A Structural MRI Study.

Authors:  Nicolle Zimmermann; Diogo Goulart Corrêa; Tadeu Almodovar Kubo; Tania Maria Netto; Denis Batista Pereira; Rochele Paz Fonseca; Emerson Leandro Gasparetto
Journal:  Clin Neuroradiol       Date:  2015-05-13       Impact factor: 3.649

5.  The Perceived Deficits Questionnaire: Perception, Deficit, or Distress?

Authors:  Lauren B Strober; Allison Binder; Olga M Nikelshpur; Nancy Chiaravalloti; John DeLuca
Journal:  Int J MS Care       Date:  2016 Jul-Aug

6.  Evaluating PROMIS(®) applied cognition items in a sample of older adults at risk for cognitive decline.

Authors:  Molly Howland; Curtis Tatsuoka; Kathleen A Smyth; Martha Sajatovic
Journal:  Psychiatry Res       Date:  2016-11-01       Impact factor: 3.222

Review 7.  Cognitive and emotional abnormalities in systemic lupus erythematosus: evidence for amygdala dysfunction.

Authors:  Philip Watson; Justin Storbeck; Paul Mattis; Meggan Mackay
Journal:  Neuropsychol Rev       Date:  2012-08-11       Impact factor: 7.444

8.  Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.

Authors:  John G Hanly; Li Su; Murray B Urowitz; Juanita Romero-Diaz; Caroline Gordon; Sang-Cheol Bae; Sasha Bernatsky; Ann E Clarke; Daniel J Wallace; Joan T Merrill; David A Isenberg; Anisur Rahman; Ellen M Ginzler; Michelle Petri; Ian N Bruce; M A Dooley; Paul Fortin; Dafna D Gladman; Jorge Sanchez-Guerrero; Kristjan Steinsson; Rosalind Ramsey-Goldman; Munther A Khamashta; Cynthia Aranow; Graciela S Alarcón; Barri J Fessler; Susan Manzi; Ola Nived; Gunnar K Sturfelt; Asad A Zoma; Ronald F van Vollenhoven; Manuel Ramos-Casals; Guillermo Ruiz-Irastorza; S Sam Lim; Kenneth C Kalunian; Murat Inanc; Diane L Kamen; Christine A Peschken; Soren Jacobsen; Anca Askanase; Chris Theriault; Kara Thompson; Vernon Farewell
Journal:  Arthritis Rheumatol       Date:  2015-07       Impact factor: 10.995

9.  A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington's disease.

Authors:  Tua Vinther-Jensen; Ida U Larsen; Lena E Hjermind; Esben Budtz-Jørgensen; Troels T Nielsen; Anne Nørremølle; Jørgen E Nielsen; Asmus Vogel
Journal:  Orphanet J Rare Dis       Date:  2014-07-17       Impact factor: 4.123

10.  Understanding and optimizing brain health in HIV now: protocol for a longitudinal cohort study with multiple randomized controlled trials.

Authors:  Nancy E Mayo; Marie-Josée Brouillette; Lesley K Fellows
Journal:  BMC Neurol       Date:  2016-01-14       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.